Duke University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duke University sits in the top decile of US sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count).
Duke University: 1,725 sponsored US clinical trials, 187 recruiting.
Duke University sponsors 1,725 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 1,244 completed. 175 of these trials are in Phase 3-4 (later-stage) and 311 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
Duke University ranks in the top decile of sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,244 of 1,444 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,725 total, page 16 of 35
Gaitbox Validation Study
NCT03406806
Blood Biomarker of Alzheimer's Disease (AD)
NCT03340571
Respiratory Control and Narcotic Effects
NCT04047550
Alpha MSH in Ocular Disease
NCT03451578
Effects of Smoking Environments on Brain Reactivity
NCT03421210
Ketogenic Diet for Reduction of CNS Oxygen Toxicity in Working Divers
NCT03433261
Self-activation in Individuals With and Without Nicotine Dependence
NCT03170258
A Comparison of Peripheral Nerve Catheter Securement Techniques at the Insertion Site in Healthy Volunteers
NCT03375190
Feasibility of Care Coordination
NCT04171596
Risk-score Based ICU Triage
NCT03390270
Stigma, Self-management, & Quality of Life in SCD
NCT03488264
Decompression Tables for Diving at Altitude
NCT03390335
BRIDGE Device for Post-operative Pain Control
NCT03265249
Role of Social Incentives in PRO Collection
NCT03436446
AML Electronic Decision Aid
NCT03442452
Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)
NCT03387033
Very Low Birth Weight Preterm Infant Bundled Care in the NICU
NCT03370757
Focal Breast Pain: Does a Normal Ultrasound Provide Reassurance?
NCT02810236
Charge: A Text Messaging-based Weight Loss Intervention
NCT03254940
Race-related Alternative Splicing: Novel Targets in Prostate Cancer
NCT03424213
Effective Management of Emotional Response to Generate Well-Being Post-HF Exacerbation
NCT03043261
Blood Biomarker in Early Parkinson's Disease
NCT03384797
Neurobehavioral Substrates of Propranolol's Effects on Drug Cue Reactivity
NCT03309943
Effects of rTMS on Human Brain Activity Measured With fMRI
NCT03259568
KeyLargo: Pembrolizumab + Oxaliplatin + Capecitabine in Gastric Cancer
NCT03342937
A Trial of an Integrated Clinic-community Intervention in Children and Adolescents With Obesity (Hearts and Parks)
NCT03339440
INJECT: A Pilot Study of Intra-tumoral Injections in Metastatic Urological Cancers
NCT03071328
Transforaminal Versus Lateralized Interlaminar Cervical Epidurals
NCT03389620
Telephone-Based Mindfulness CBT for Patients in Community Settings With Advanced Cancer
NCT03285633
Fathers Raising Responsible Men (FRRM): Addressing Sexual Health
NCT03429985
Feasibility of VIIT in Adults With NASH
NCT03861819
Glenohumeral Rotation After Throwing: RCT Comparing the Sleeper Stretch to the 90/90 Hip Lift With Balloon Blow Exercise
NCT03091530
Utilizing Gaze Training to Enhance Laparoscopic Skills Training
NCT03413943
Parent Educational Discharge Support Strategies
NCT03227068
Study to Test the Feasibility, Acceptability, and Weight Change of Take Off Pounds Sensibly (TOPS) in a Safety Net Clinic
NCT03202420
A Randomized Trial of CT Fluoroscopy-guided Targeted Autologous Blood and Fibrin Glue Patching for Treatment
NCT03276975
Use of ARINA-1 in an Intermediate Size Patient Population of Bilateral Lung Transplant Patients With CLAD Grade 0
NCT03226431
Assessment of InfraScanner 2000™ in Detecting Subdural and Epidural Hematomas
NCT03353246
Locally Advanced NSCLC Hyperfractionated RT
NCT03128008
Pilot Study Assessing Breast Temperature in Breast Cancer Patients
NCT03376035
Prosthetics Registry and Outcomes in Urology at Duke
NCT03323645
Pain Coping Skills and Meaning-Centered Intervention
NCT03207360
Cannabis Use and Epigenetic Alterations in Human Male Sperm Cells
NCT03614637
Fulfillment of Expectations for Patients With FAI Syndrome
NCT03278353
Pompe Gene Therapy- Screening for Eligibility
NCT03285126
Ocular Screening in Children and Young Adults at Risk for Increased Intracranial Pressure
NCT03286426
Antibiotic Prophylaxis in Patients Undergoing Elective Total Knee Arthroplasty- Multi-center Trial
NCT03283878
Theta Burst Stimulation for Schizophrenia
NCT03288779
Effect of Prebiotic Fiber- Enriched (scFOS) Enteral Feeding on the Microbiome in Neurological Injury Trauma Patients (PreFEED Microbiome Trial)
NCT03153397
The Treatment Preferences of Women Diagnosed With Ovarian Cancer
NCT03367260
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 136 |
| Phase 2 | 175 |
| Phase 3 | 41 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Duke University pipeline
187 recruiting of 1,725 indexed (11% open); 1,244 completed (72%).
Phase mix: 175 late (III/IV) vs 311 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duke University: open-pipeline peers nationwide
Peers matched on 1,725 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Duke University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,725 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Carnegie Mellon University · 11% recruiting · 37 trials
- CAMC Health System · 11% recruiting · 28 trials
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
Related
What to do with this Duke University page
1,725 registered trials is a research-attention snapshot, not an endorsement of Duke University or any single study.
- 187 of Duke University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Duke University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duke University pipeline card: 1,725 registered trials from official public datasets.Report a data error.